113 related articles for article (PubMed ID: 7736535)
1. Study of peripheral blood lymphocyte subset distribution and IL-2 receptor (IL-2 R) p55-p75 subunit expression in patients with cancer of different sites.
Mantovani G; Macciò A; Lai P; Turnu E; Del Giacco GS
Cell Biophys; 1994; 24-25():301-5. PubMed ID: 7736535
[TBL] [Abstract][Full Text] [Related]
2. Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies.
Mantovani G; Macciò A; Astara G; Contini L; Esu S; Littera S; Arangino V; Lai P; Proto E; Pusceddu G
Cell Biophys; 1993; 22(1-3):79-99. PubMed ID: 7889544
[TBL] [Abstract][Full Text] [Related]
3. [p55 and p75 subunits of the IL 2 receptor, membrane bound and soluble, in peripheral lymphocytes in patients with solid tumors].
Mantovani G; Macciò A; Contini L; Esu S; Littera S; Lai P; Proto E; Balestrieri A; Del Giacco GS
Recenti Prog Med; 1993 Jun; 84(6):415-22. PubMed ID: 8516548
[TBL] [Abstract][Full Text] [Related]
4. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G
Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of the IL-2 receptor subunits, p55 and p75 on various populations of primary peripheral blood mononuclear cells.
Ohashi Y; Takeshita T; Nagata K; Mori S; Sugamura K
J Immunol; 1989 Dec; 143(11):3548-55. PubMed ID: 2584707
[TBL] [Abstract][Full Text] [Related]
6. Contribution of serum inhibitory factors and immune cellular defects to the depressed cell-mediated immunity in patients with head and neck cancer.
Wanebo HJ; Blackinton D; Kouttab N; Mehta S
Am J Surg; 1993 Oct; 166(4):389-94. PubMed ID: 8214299
[TBL] [Abstract][Full Text] [Related]
7. Restoration of functional defects in peripheral blood mononuclear cells isolated from cancer patients by thiol antioxidants alpha-lipoic acid and N-acetyl cysteine.
Mantovani G; Macciò A; Melis G; Mura L; Massa E; Mudu MC
Int J Cancer; 2000 Jun; 86(6):842-7. PubMed ID: 10842199
[TBL] [Abstract][Full Text] [Related]
8. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G
Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954
[TBL] [Abstract][Full Text] [Related]
9. Activation of the immune system of cancer patients by continuous i.v. recombinant IL-2 (rIL-2) therapy is dependent on dose and schedule of rIL-2.
Gratama JW; Bruin RJ; Lamers CH; Oosterom R; Braakman E; Stoter G; Bolhuis RL
Clin Exp Immunol; 1993 May; 92(2):185-93. PubMed ID: 8485906
[TBL] [Abstract][Full Text] [Related]
10. Preovulatory human follicular fluid in vitro inhibits interleukin (IL)-1 alpha, IL-2, and production and expression of p55 chain IL-2 receptor of lymphomonocytes.
Macciò A; Mantovani G; Turnu E; Artini P; Contu G; Volpe A
Fertil Steril; 1994 Aug; 62(2):327-32. PubMed ID: 8034080
[TBL] [Abstract][Full Text] [Related]
11. Activation of peripheral blood T cells via the p75 interleukin 2 receptor.
Yagita H; Nakata M; Azuma A; Nitta T; Takeshita T; Sugamura K; Okumura K
J Exp Med; 1989 Oct; 170(4):1445-50. PubMed ID: 2571670
[TBL] [Abstract][Full Text] [Related]
12. Reduced LAK cytotoxicity of peripheral blood mononuclear cells in patients with bladder cancer: decreased LAK cytotoxicity caused by a low incidence of CD56+ and CD57+ mononuclear blood cells.
Hermann GG; Petersen KR; Steven K; Zeuthen J
J Clin Immunol; 1990 Nov; 10(6):311-20. PubMed ID: 1707414
[TBL] [Abstract][Full Text] [Related]
13. Expression of p75 chain of IL-2 receptor in the early immunological reconstitution after allogeneic bone marrow transplantation.
Comoli P; Maccario R; Montagna D; Labirio M; Zecca M; Clementi R; Bonetti F; Locatelli F
Clin Exp Immunol; 1994 Sep; 97(3):510-6. PubMed ID: 8082308
[TBL] [Abstract][Full Text] [Related]
14. Generation of human lymphokine-activated killer cells following an IL-2 pulse in elderly cancer patients.
Provinciali M; Di Stefano G; Stronati S; Fabris N
Cytokine; 1998 Feb; 10(2):132-9. PubMed ID: 9512903
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints.
Brennan FM; Gibbons DL; Mitchell T; Cope AP; Maini RN; Feldmann M
Eur J Immunol; 1992 Jul; 22(7):1907-12. PubMed ID: 1320571
[TBL] [Abstract][Full Text] [Related]
16. IL-7 regulation of cytotoxic lymphocytes: pore-forming protein gene expression, interferon-gamma production, and cytotoxicity of human peripheral blood lymphocytes subsets.
Smyth MJ; Norihisa Y; Gerard JR; Young HA; Ortaldo JR
Cell Immunol; 1991 Dec; 138(2):390-403. PubMed ID: 1834347
[TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: expression of both p55 and p75 subunits is affected.
Krause DS; Deutsch C
J Immunol; 1991 Apr; 146(7):2285-96. PubMed ID: 1848580
[TBL] [Abstract][Full Text] [Related]
18. Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients.
Mantovani G; Macciò A; Esu S; Lai P; Santona MC; Massa E; Dessì D; Melis GB; Del Giacco GS
Eur J Cancer; 1997 Apr; 33(4):602-7. PubMed ID: 9274442
[TBL] [Abstract][Full Text] [Related]
19. IL-4 synergizes with IL-10 and anti-CD40 MoAbs to induce B-cell differentiation in patients with common variable immunodeficiency.
Punnonen J; Kainulainen L; Ruuskanen O; Nikoskelainen J; Arvilommi H
Scand J Immunol; 1997 Feb; 45(2):203-12. PubMed ID: 9042433
[TBL] [Abstract][Full Text] [Related]
20. Functional role of IL-2 receptors on tumour-infiltrating lymphocytes.
Trentin L; Zambello R; Bulian P; Cerutti A; Milani A; Pirone E; Nitti D; Agostini C; Semenzato G
Br J Cancer; 1994 Jun; 69(6):1046-51. PubMed ID: 8198969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
